{
  "@context": "aku-v2",
  "@type": "clinical-syndrome",
  "@id": "vasc:rare:retroperitoneal-fibrosis",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:23:00.000Z",
    "updated": "2026-01-07T03:23:00.000Z",
    "contributors": ["knowledge-graph-agent"],
    "confidence": 0.90,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/rare-syndromes",
    "type": "fibrotic-disease",
    "difficulty": "advanced",
    "importance": "high"
  },
  "content": {
    "title": "Retroperitoneal Fibrosis",
    "description": "Fibroinflammatory process encasing retroperitoneal structures including aorta and ureters",
    "key_concepts": [
      {
        "concept": "Etiology",
        "details": "Idiopathic (most common), inflammatory aortic aneurysm, drugs (ergots, methysergide), IgG4-related"
      },
      {
        "concept": "Vascular Involvement",
        "details": "Periaortic/peri-iliac fibrosis; may cause ureteral obstruction, venous compression"
      },
      {
        "concept": "Imaging",
        "details": "CT shows soft tissue rind around aorta; distinguishing from inflammatory aneurysm important"
      },
      {
        "concept": "Treatment",
        "details": "Corticosteroids for idiopathic; tamoxifen; ureteral stenting; surgical ureterolysis"
      }
    ],
    "clinical_significance": "Consider in AAA patients with periaortic tissue mass and ureteral involvement"
  },
  "provenance": {
    "primary_sources": ["Vaglio A et al. Lancet 2006"]
  }
}
